FT. LAUDERDALE, Fla., May 25, 2011 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferré, M.D., President and Chief Executive Officer of MAKO, will present at the Goldman Sachs 32nd Annual Global Healthcare Conference at the Terranea Resort at Ranchos Palos Verdes, CA on Thursday, June 9, 2011 at 10:40 am PT.
A webcast will be available and may be accessed by visiting MAKO's website at under the Investor Relations section. A replay of the webcast will be available immediately after the conclusion of the presentation.
About MAKO Surgical Corp.
MAKO Surgical Corp. is a medical device company that markets both its RIO® Robotic-Arm Interactive Orthopedic system and its proprietary RESTORIS® implants for minimally invasive orthopedic knee procedures. The MAKO RIO is a surgeon-interactive tactile surgical platform that incorporates a robotic arm and patient-specific visualization technology and prepares the knee joint for the insertion and alignment of MAKO's resurfacing RESTORIS implants through a minimal incision. The FDA-cleared and CE Marked RIO system allows surgeons to provide a precise, consistently reproducible tissue-sparing, bone resurfacing procedure called MAKOplasty® to a large, yet underserved patient population suffering from early to mid-stage osteoarthritic knee disease. The MAKOplasty solution is comprised of imaging, navigation, surgical procedures, haptics, robotics, software, instrument and implant technologies and is enabled by an intellectual property portfolio of more than 300 U.S. and foreign, owned and licensed, patents and patent applications, as well as copyrights, trademarks, trade secrets and employee know-how. Additional information can be found at .
CONTACT: Investors: MAKO Surgical Corp. Susan M. Verde 954-628-1706 investorrelations@makosurgical.com Westwicke Partners Mark Klausner 443-213-0500 makosurgical@westwicke.com